Health Services and Systems Research, Duke-NUS Medical School, Singapore.
Health Services and Systems Research, Duke-NUS Medical School, Singapore; Faculty of Dentistry, National University of Singapore, Singapore.
Epilepsy Behav. 2022 Oct;135:108880. doi: 10.1016/j.yebeh.2022.108880. Epub 2022 Aug 17.
To identify parents' priorities when making a decision on genetic testing and antiseizure drug (ASD) options for pediatric epilepsy and their support needs for informed decision-making in multi-ethnic Asian clinical settings.
Qualitative in-depth interviews, using a semi-structured interview guide, were conducted with purposively selected parents of pediatric patients with newly diagnosed epilepsy or known diagnosis of epilepsy (n = 26). Interviews were audio recorded and transcribed verbatim. Thematic analysis was undertaken to generate themes.
Parents' narratives showed difficulty assimilating information, while knowledge deficit and emotional vulnerability led parents' desire to defer a decision for testing and ASDs to mitigate decisional burden. Priorities for decisions were primarily based on intuitive ideas of the treatment's risks and benefits, yet very few could elaborate on tradeoffs between risks and efficacy. Priorities outside the purview of the healthcare team, such as children's emotional wellbeing and family burden of ASD administration, were also considered important. Authority-of-medical-professional heuristic facilitated the ASD decision for parents who preferred shared rather than sole responsibility for a decision. Importantly, parents' support needs for informed decision-making were very much related to the availability of support mechanisms in post-treatment decisions owing to perceived uncertainty of the chosen ASD.
Findings suggest that multiple priorities influenced ASD decision process. To address support needs of parents for informed decision-making, more consideration should be given to post-treatment decision support through the provision of educational opportunities, building peer support networks, and developing a novel communication channel between healthcare providers and parents.
确定父母在决定对儿科癫痫患者进行基因检测和选择抗癫痫药物(ASD)时的优先事项,以及在多民族亚洲临床环境中做出知情决策时他们对决策支持的需求。
采用半结构式访谈指南,对新诊断为癫痫或已知癫痫诊断的儿科患者的家长(n=26)进行了定性深入访谈。访谈进行了录音并逐字转录。采用主题分析生成主题。
家长的叙述表明他们难以理解信息,而知识不足和情绪脆弱导致家长希望推迟进行检测和 ASD 的决定,以减轻决策负担。决策的优先事项主要基于对治疗风险和益处的直观想法,但很少有人能详细说明风险和疗效之间的权衡。除医疗团队关注的范围之外,例如孩子的情绪健康和 ASD 管理对家庭的负担,也被认为很重要。家长更喜欢共同而不是单独承担决策责任,因此,医学专业人员的权威性启发式也有助于 ASD 的决策。重要的是,家长对知情决策的支持需求与治疗后决策中支持机制的可用性密切相关,因为他们认为所选 ASD 的不确定性很大。
研究结果表明,多个优先事项影响了 ASD 决策过程。为了满足家长对知情决策的支持需求,应更多地考虑通过提供教育机会、建立同伴支持网络以及在医疗保健提供者和家长之间开发新的沟通渠道来为治疗后决策提供支持。